Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control
Sponsor: Sunhawk Vision Biotech, Inc.
Summary
The objective of this study is to explore the safety and efficacy of SHJ002 Sterile Ophthalmic Solution relative to atropine in myopia control SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.
Official title: A Phase II Study to Determine the Safety and Efficacy of SHJ002 Sterile Ophthalmic Solution on Myopia Control in Subjects Aged 3-12 Years.
Key Details
Gender
All
Age Range
3 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2025-01-22
Completion Date
2026-12
Last Updated
2026-01-23
Healthy Volunteers
No
Conditions
Interventions
SHJ002
Topical ophthalmic
Atropine
Topical ophthalmic
Locations (9)
Pacific Center for Advanced Vision Care Tanasbourne Vision Center
Hillsboro, Ohio, United States
Changhua Christian Hospital
Chang-hua, Taiwan
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
Chang Cung Memorial Hospital-Tucheng
New Taipei City, Taiwan
MacKay Memorial Hospital-Tamsui
New Taipei City, Taiwan
Chung Shan Medical University Hospital
Taichung, Taiwan
Cathay General Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Tri-Service General Hospital
Taipei, Taiwan